Prostate Cancer Trial, Recruiting NCT06633380 Sponsor: University of Toronto Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06633380
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who have gone through menopause, were born female, and have been diagnosed with stage I, II, or III breast cancer, and have been taking aromatase inhibitor medication for at least 3 months before the study begins
  • People with a body mass index (BMI) of 25 or higher (a measure of body weight relative to height)
  • People who report eating three main meals per day
  • People who report being mostly inactive — meaning less than 30 minutes per week of moderate or vigorous exercise, and doing muscle-strengthening activities less than twice per week, over the past three months

Who may not be able to join:

  • People who are unwilling or unable to get medical clearance from a doctor after being checked for signs of heart disease, diabetes, or kidney disease, or who are assessed as not safe to begin exercise — including those who experience symptoms such as chest pain, shortness of breath at rest or with light activity, dizziness or fainting, swollen ankles, irregular or fast heartbeat, leg pain when walking, a known heart murmur, or unusual tiredness during everyday activities
  • People who are currently taking medication to manage diabetes (such as insulin, Ozempic, or metformin) or who have lost more than 5 kg in the past 3 months for any reason
  • People who have an injury or other reason that would prevent them from completing a 30-minute continuous walk or muscle-strengthening exercises
  • People without access to an Ontario LifeLabs location for a fasting blood test (one taken after not eating overnight)
  • People who do not have a smartphone that works with the apps required for the study
  • People who are unable to read, understand, or communicate in English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-946-4069

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Toronto
Registry
ClinicalTrials.gov
Start date
22 October 2024
Est. completion
30 April 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

24-hour glucose incremental area under the curve (iAUC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov